Scarica l'app Stockscreener
2.46
3.91%
-0.10
Dopo l'orario di chiusura:
2.46
Precedente Chiudi:
$2.56
Aprire:
$2.56
Volume 24 ore:
622.93K
Relative Volume:
0.98
Capitalizzazione di mercato:
$174.00M
Reddito:
$299.48M
Utile/perdita netta:
$-86.45M
Rapporto P/E:
-1.64
EPS:
-1.5
Flusso di cassa netto:
$-17.32M
1 W Prestazione:
-5.38%
1M Prestazione:
+0.00%
6M Prestazione:
-38.19%
1 anno Prestazione:
-69.29%
Intervallo 1D:
$2.44
$2.62
Intervallo di 1 settimana:
$2.44
$2.69
Portata 52W:
$2.015
$8.0956
Health Catalyst Inc Stock (HCAT) Company Profile
Nome
Health Catalyst Inc
Settore
Industria
Telefono
801-708-6800
Indirizzo
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Confronta HCAT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
2.46 | 181.07M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
223.26 | 37.72B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
70.61 | 13.14B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
96.79 | 8.32B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
43.85 | 8.31B | 550.17M | 201.35M | 232.07M | 1.00 |
|
BTSG
Brightspring Health Services Inc
|
36.54 | 6.47B | 11.99B | 24.18M | 234.31M | 0.2956 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-27 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Downgrade | Citigroup | Buy → Neutral |
| 2025-08-08 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2024-01-03 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-05-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Iniziato | Stephens | Equal-Weight |
| 2023-04-04 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Iniziato | Wells Fargo | Equal Weight |
| 2022-10-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Downgrade | Stifel | Buy → Hold |
| 2022-04-14 | Iniziato | Guggenheim | Buy |
| 2022-03-17 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2021-12-02 | Iniziato | Jefferies | Hold |
| 2021-10-14 | Iniziato | BTIG Research | Buy |
| 2021-04-29 | Ripresa | JP Morgan | Overweight |
| 2020-12-08 | Iniziato | Berenberg | Buy |
| 2020-07-14 | Iniziato | Citigroup | Buy |
| 2020-06-18 | Iniziato | Stifel | Buy |
| 2020-06-15 | Ripresa | Evercore ISI | Outperform |
| 2020-05-15 | Iniziato | Guggenheim | Buy |
| 2020-04-21 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-04-13 | Iniziato | SVB Leerink | Outperform |
| 2020-04-02 | Iniziato | Canaccord Genuity | Buy |
| 2019-12-20 | Iniziato | Raymond James | Strong Buy |
| 2019-10-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Iniziato | Evercore ISI | Outperform |
| 2019-08-19 | Iniziato | Goldman | Buy |
| 2019-08-19 | Iniziato | JP Morgan | Overweight |
| 2019-08-19 | Iniziato | Piper Jaffray | Overweight |
| 2019-08-19 | Iniziato | SVB Leerink | Outperform |
| 2019-08-19 | Iniziato | SunTrust | Buy |
| 2019-08-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Health Catalyst Inc Borsa (HCAT) Ultime notizie
Health Catalyst (NASDAQ:HCAT) General Counsel Benjamin Landry Sells 27,425 Shares - MarketBeat
Health Catalyst (NASDAQ:HCAT) Director Sells $128,151.99 in Stock - MarketBeat
Health Catalyst's Market Cap Drops To US$190m Leaving Insiders With Losses - simplywall.st
What technical patterns form on Health Catalyst Inc. (2YP) stock chartsWeekly Market Outlook & Precise Buy Zone Tips - Newser
How Health Catalyst Inc. (2YP) stock behaves in tightening cyclesLong Setup & Weekly Market Pulse Alerts - Newser
Is Health Catalyst Inc. (2YP) stock positioned for digital growth era2025 Market Overview & Fast Moving Stock Watchlists - Newser
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Is Health Catalyst Inc. (2YP) stock supported by free cash flowWeekly Investment Summary & Stock Timing and Entry Methods - Newser
Why Health Catalyst Inc stock is a must watch in 2025 - BỘ NỘI VỤ
Officer Freeman Surrenders 16,401 Of Health Catalyst Inc [HCAT] - TradingView
Will Health Catalyst Inc. (2YP) stock sustain bullish trend into 20252025 Technical Overview & Weekly High Return Forecasts - Newser
Health Catalyst appoints largest shareholder’s CEO to board By Investing.com - Investing.com Canada
Is Health Catalyst Inc. (2YP) stock expanding market penetrationJuly 2025 Summary & Real-Time Volume Analysis Alerts - Newser
Can Health Catalyst Inc. (2YP) stock sustain breakout momentumJuly 2025 Earnings & Daily Stock Trend Reports - Newser
Matt Arens, CEO and founder of Health Catalyst's largest shareholder, First Light Asset Management, joins board of directors - marketscreener.com
Matt Arens, CEO And Founder Of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board Of Directors - TradingView
Health Catalyst appoints largest shareholder’s CEO to board - Investing.com
Health Catalyst Appoints New Board Member Matt Arens - TipRanks
Health Catalyst Appoints Matt Arens to Board of Directors - TradingView
Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors - PR Newswire
Will Health Catalyst Inc. (2YP) stock justify high valuationWeekly Profit Recap & AI Driven Price Forecasts - Newser
Will Health Catalyst Inc. (2YP) stock gain from lower interest ratesTrade Signal Summary & Entry Point Strategy Guides - Newser
Officer Ross Files To Sell 4,793 Of Health Catalyst Inc [HCAT] - TradingView
Why Health Catalyst Inc. stock is a must watch in 2025July 2025 Short Interest & AI Forecasted Entry/Exit Points - moha.gov.vn
Can Health Catalyst Inc. stock deliver strong Q4 earnings2025 Dividend Review & Fast Gain Stock Trading Tips - BỘ NỘI VỤ
Health Catalyst and Unity Stocks Trade Up, What You Need To Know - The Globe and Mail
Health Catalyst and ON24 Stocks Trade Up, What You Need To Know - The Globe and Mail
Can Health Catalyst Inc. (2YP) stock hold up in economic slowdownQuarterly Earnings Summary & Fast Exit and Entry Strategy Plans - newser.com
Unity, Wix, Upstart, Samsara, and Health Catalyst Shares Are Falling, What You Need To Know - The Globe and Mail
Why Health Catalyst Inc. stock could outperform in 2025Breakout Watch & Capital Efficient Trade Techniques - newser.com
Health Catalyst Inc. stock trend outlook and recovery pathQuarterly Earnings Summary & Intraday High Probability Setup Alerts - newser.com
Health Catalyst (HCAT) Price Target Decreased by 11.25% to 4.02 - MSN
Identifying reversal signals in Health Catalyst Inc.July 2025 Drop Watch & Community Shared Stock Ideas - newser.com
Is Health Catalyst Inc. (2YP) stock good for wealth creation2025 Stock Rankings & Daily Market Momentum Tracking - newser.com
Will Health Catalyst Inc. stock benefit from green energy trends2025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com
Health Catalyst Inc Azioni (HCAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.32%
6.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):